REH Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | REH is a human B-cell precursor acute lymphoblastic leukemia (ALL) cell line derived in 1973 from the peripheral blood of a 15-year-old patient during relapse. As one of the earliest established B-precursor ALL models, it displays typical lymphoblastic morphology and grows in suspension culture, reflecting the behavior of leukemia blasts. REH cells are widely used to investigate B-ALL biology, including proliferation, survival pathways, and treatment response. They support both in vitro drug-screening studies and in vivo leukemia modeling through xenograft experiments in immunodeficient mice, making them a versatile tool for preclinical research on novel therapeutic strategies. |
|---|---|
| Organism | Human |
| Tissue | Peripheral blood |
| Disease | Acute lymphoblastic leukemia (ALL) |
| Synonyms | Reh |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Round cells |
| Cell type | Lymphoblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | REH (Cytion catalog number 300320) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1650 |
Biomolecular Data
| Antigen expression | CD3 A (17%) B (17%) C (20%), CD4 (15%), CD10 (55%), CD20+, HLA-DR+, CALLA+ |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300320-031125 | Certificate of Analysis | 05. Dec. 2025 | 300320 |